Here, we showed that both miR-21 and Spry2 could affect MAPK/ERK and PI3K/AKT signal pathway, which further explains the role of miR-21 and Spry2 in pancreatic cancer cell proliferation. This evidence concerns the gene SPRY2 and familial pancreatic carcinoma.